Company profile for Immorta Bio

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Immorta Bio is a regenerative medicine company dedicated to treating aging and age-related diseases by harnessing patients’ own young stem cells and enhanced immune cells. Their mission is to reverse aging, eliminate cancer, and rejuvenate organs. Their technology platforms include SenoVax™, an autologous senolytic immunotherapy targeting senescent cells, and StemCellRevivify™, aimed at rebuilding damaged tissues and org...
Immorta Bio is a regenerative medicine company dedicated to treating aging and age-related diseases by harnessing patients’ own young stem cells and enhanced immune cells. Their mission is to reverse aging, eliminate cancer, and rejuvenate organs. Their technology platforms include SenoVax™, an autologous senolytic immunotherapy targeting senescent cells, and StemCellRevivify™, aimed at rebuilding damaged tissues and organs.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
19505 Biscayne Blvd, Ste 2350 Aventura, Florida 33180
Telephone
Telephone
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.prnewswire.com/news-releases/immorta-bio-announces-publication-of-international-patent-application-for-senovax-a-first-in-class-senolytic-immunotherapy-302625673.html

PR NEWSWIRE
25 Nov 2025

https://www.prnewswire.com/news-releases/immorta-bio-expands-stemcellrevivify-platform-to-harness-autologous-younger-mitochondria-for-regeneration-of-heart-brain-and-liver-302592804.html

PR NEWSWIRE
23 Oct 2025

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty